Ocugen Statistics

Total Valuation

Ocugen has a market cap or net worth of EUR 317.02 million. The enterprise value is 317.36 million.

Market Cap	317.02M
Enterprise Value	317.36M

Important Dates

The next estimated earnings date is Monday, March 2, 2026.

Earnings Date	Mar 2, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	312.32M
Shares Outstanding	n/a
Shares Change (YoY)	+12.36%
Shares Change (QoQ)	+4.09%
Owned by Insiders (%)	1.49%
Owned by Institutions (%)	14.82%
Float	307.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	69.27
PB Ratio	105.28
P/TBV Ratio	105.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.82
EV / Sales	68.70
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.96

Financial Position

The company has a current ratio of 1.85, with a Debt / Equity ratio of 9.33.

Current Ratio	1.85
Quick Ratio	1.60
Debt / Equity	9.33
Debt / EBITDA	n/a
Debt / FCF	-0.62
Interest Coverage	-16.16

Financial Efficiency

Return on equity (ROE) is -289.93% and return on invested capital (ROIC) is -90.71%.

Return on Equity (ROE)	-289.93%
Return on Assets (ROA)	-63.67%
Return on Invested Capital (ROIC)	-90.71%
Return on Capital Employed (ROCE)	-163.53%
Revenue Per Employee	48,177
Profits Per Employee	-574,360
Employee Count	95
Asset Turnover	0.09
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +12.09% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+12.09%
50-Day Moving Average	1.27
200-Day Moving Average	0.90
Relative Strength Index (RSI)	48.83
Average Volume (20 Days)	11,207

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	12.10

Income Statement

In the last 12 months, Ocugen had revenue of EUR 4.58 million and -54.56 million in losses. Loss per share was -0.19.

Revenue	4.58M
Gross Profit	-27.27M
Operating Income	-51.90M
Pretax Income	-54.56M
Net Income	-54.56M
EBITDA	-49.01M
EBIT	-51.90M
Loss Per Share	-0.19

Full Income Statement

Balance Sheet

The company has 27.76 million in cash and 28.10 million in debt, giving a net cash position of -340,068.

Cash & Cash Equivalents	27.76M
Total Debt	28.10M
Net Cash	-340,068
Net Cash Per Share	n/a
Equity (Book Value)	3.01M
Book Value Per Share	0.01
Working Capital	14.73M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -45.48 million and capital expenditures -138,925, giving a free cash flow of -45.62 million.

Operating Cash Flow	-45.48M
Capital Expenditures	-138,925
Free Cash Flow	-45.62M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,133.87%
Pretax Margin	-1,192.18%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Ocugen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.36%
Shareholder Yield	-12.36%
Earnings Yield	-17.21%
FCF Yield	-14.39%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Ocugen has an Altman Z-Score of -9.61 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-9.61
Piotroski F-Score	2